Answers are grounded in this paper and cite their sources.
Shows targeted plasma proteomics outperforms clinical risk factors in predicting cardiovascular events, suggesting potential value for primary prevention.
In a primary prevention setting, a proteome-based model outperforms a model comprising clinical risk factors in predicting the risk of CV events. Validation in a large prospective primary prevention cohort is required to address the value for future clinical implementation in CV prevention.
No takes yet. Share an insight, caveat, or question.
Hoogeveen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: